No evidence of Gremlin1-mediated activation of VEGFR2 signaling in endothelial cells

Louise R. Dutton, Christina L. O'Neill, Reinhold J. Medina, Derek P. Brazil

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)
169 Downloads (Pure)


Canonical Gremlin1 (GREM1) signaling involves binding to and sequestering bone morphogenetic proteins (BMPs) in the extracellular matrix, preventing the activation of cognate BMP receptor. Exquisite temporospatial control of the GREM1-BMP interaction is required during development, and perturbation of this balance leads to abnormal limb formation and defective kidney development. In addition to inhibition of BMP signaling, several other noncanonical signaling modalities of GREM1 have been postulated. Some literature reports have suggested that GREM1 can bind to and activate vascular endothelial growth factor receptor-2 (VEGFR2) in endothelial cells, human kidney epithelial cells, and others. These reports suggest that the GREM1 → VEGFR2 signaling can drive angiogenesis both in vitro and in vivo We report here that, despite exhaustive attempts, we did not observe GREM1 activation of VEGFR2 in any of the cell lines reported by the above-mentioned studies. Incubation of endothelial colony-forming cells (ECFCs) or human umbilical vein endothelial cells (HUVECs) with recombinant VEGF triggered a robust increase in VEGFR2 tyrosine phosphorylation. In contrast, no VEGFR2 phosphorylation was detected when cells were incubated with recombinant GREM1 over a range of time points and concentrations. We also show that GREM1 does not interfere with VEGF-mediated VEGFR2 activation, suggesting that GREM1 does not bind with any great affinity to VEGFR2. Measurements of ECFC barrier integrity revealed that VEGF induces barrier function disruption, but recombinant human GREM1 had no effect in this assay. We believe that these results provide an important clarification of the potential interaction between GREM1 and VEGFR2 in mammalian cells.

Original languageEnglish
Pages (from-to)18041-18045
Number of pages5
JournalThe Journal of Biological Chemistry
Issue number48
Early online date11 Oct 2019
Publication statusPublished - 29 Nov 2019

Bibliographical note

Published under license by The American Society for Biochemistry and Molecular Biology, Inc.


  • angiogenesis
  • bone morphogenetic protein (BMP)
  • cancer biology
  • cell signaling
  • cell surface receptor
  • Gremlin1
  • protein phosphorylation
  • vascular biology
  • vascular endothelial growth factor (VEGF)

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'No evidence of Gremlin1-mediated activation of VEGFR2 signaling in endothelial cells'. Together they form a unique fingerprint.

Cite this